Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 18, 2023
Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkers
Katia E Maalouf, Christine A Vaine, Dawn M Frederick, et al.
Bioorganic & Medicinal Chemistry
|
August 7, 2024
Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity
Hideaki Kageji, Takayuki Momose, Masayuki Ebisawa, et al.
Bioorganic & Medicinal Chemistry
|
October 17, 2025
Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Yukinobu Numata, Toru Hasegawa, Makoto Mori, et al.
Molecular Cancer Therapeutics
|
July 10, 2025
DS-3939a: A TA-MUC1-directed Antibody-Drug Conjugate with Broad Anti-Tumor Activity
Kohei Takano, Mayuko Yukiura, Kazuki Takahashi, et al.
European Journal of Pharmacology
|
November 9, 2023
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
Genzui Setsu, Megumi Goto, Kentaro Ito, et al.
Journal of Extracellular Vesicles
|
June 17, 2025
Engineering of CD63 Enables Selective Extracellular Vesicle Cargo Loading and Enhanced Payload Delivery
Wataru Obuchi, Ayrton Zargani-Piccardi, Kevin Leandro, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 18, 2023
Tracking human neurologic disease status in mouse brain/plasma using reporter-tagged, EV-associated biomarkers
Katia E Maalouf, Christine A Vaine, Dawn M Frederick, et al.
Bioorganic & Medicinal Chemistry
|
August 7, 2024
Discovery of a potent, selective, and orally available EGFR C797S mutant inhibitor (DS06652923) with in vivo antitumor activity
Hideaki Kageji, Takayuki Momose, Masayuki Ebisawa, et al.
Bioorganic & Medicinal Chemistry
|
October 17, 2025
Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors
Yukinobu Numata, Toru Hasegawa, Makoto Mori, et al.
Molecular Cancer Therapeutics
|
July 10, 2025
DS-3939a: A TA-MUC1-directed Antibody-Drug Conjugate with Broad Anti-Tumor Activity
Kohei Takano, Mayuko Yukiura, Kazuki Takahashi, et al.
European Journal of Pharmacology
|
November 9, 2023
Highly potent, orally active novel small-molecule HPK1 inhibitor DS21150768 induces anti-tumor responses in multiple syngeneic tumor mouse models
Genzui Setsu, Megumi Goto, Kentaro Ito, et al.
Journal of Extracellular Vesicles
|
June 17, 2025
Engineering of CD63 Enables Selective Extracellular Vesicle Cargo Loading and Enhanced Payload Delivery
Wataru Obuchi, Ayrton Zargani-Piccardi, Kevin Leandro, et al.
Page
of 2